Get the Stockscreener App
100.97
0.01%
-0.01
After Hours:
100.97
Lantheus Holdings Inc stock is traded at $100.97, with a volume of 833.22K.
It is down -0.01% in the last 24 hours and down -0.14% over the past month.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
See More
Previous Close:
$100.98
Open:
$100.75
24h Volume:
833.22K
Relative Volume:
0.65
Market Cap:
$6.59B
Revenue:
$1.54B
Net Income/Loss:
$233.56M
P/E Ratio:
29.99
EPS:
3.3669
Net Cash Flow:
$348.64M
1W Performance:
+0.20%
1M Performance:
-0.14%
6M Performance:
+29.71%
1Y Performance:
+87.61%
1-Day Range:
$100.75
$101.00
1-Week Range:
$100.54
$101.43
52-Week Range:
$49.67
$111.86
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
100.97 | 6.54B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-12-25 | Upgrade | Truist | Hold → Buy |
| Oct-08-25 | Downgrade | Goldman | Buy → Neutral |
| Aug-12-25 | Downgrade | Truist | Buy → Hold |
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value - Stocktwits
Lantheus alpha therapy, CATX director, sells $131k in stock By Investing.com - Investing.com Australia
Lantheus alpha therapy, CATX director, sells $131k in stock - Investing.com
Perspective Therapeutics (CATX) Insider Sell: 10% Owner Lantheus Alpha Therapy, LLC Disposes of 42,129 Shares - GuruFocus
Lantheus Holdings (NASDAQ: LNTH) Disposes of 35,769 Perspective Therapeutics Shares at $3.12 Each - kalkinemedia.com
Perspective Therapeutics (CATX) backer trims stake but keeps 11.5M shares - Stock Titan
10% owner of Perspective Therapeutics (NYSE: CATX) sells 113,914 shares over two days - Stock Titan
Perspective Therapeutics (CATX) backer Lantheus now owns 10% after share sales - Stock Titan
Perspective Therapeutics Inc (CATX) Insider Sell: 10% Owner Holdings, Lantheus Disposes of 35,769 Shares - GuruFocus
Perspective Therapeutics (CATX) holder sells 35K shares, still owns 11.6M - Stock Titan
Perspective Therapeutics Inc (CATX) Insider Sell: 10% Owner Holdings, Lantheus Disposes of 78,145 Shares - GuruFocus
Lantheus Holdings sells $245,609 in Perspective Therapeutics stock By Investing.com - Investing.com Nigeria
Lantheus Holdings sells $245,609 in Perspective Therapeutics stock - Investing.com
Technical Reactions to LNTH Trends in Macro Strategies - news.stocktradersdaily.com
Lantheus Holdings, Inc. (LNTH): Analyst Consensus and Growth Potential Amid Healthcare Innovations - DirectorsTalk Interviews
Lantheus Holdings 1Q Net $118.4M >LNTH - Moomoo
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders - The Daily Tribune News
Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH) - Yahoo Finance
Lantheus (LNTH) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in Latest Trading; Session Move - Vinanet
Lantheus Holdings CAO Kimberly Brown Sells 463 Shares for Tax Withholding Purposes - Kalkine Media
Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $106.3, Implies 6% Upside - TradingView
Lantheus (LNTH) Q2 2026 Filing Snapshot: The EPS Result Is Above Expectation in the Current Update; Market Follow-Through: The Stock Records a 0.64% Decrease on the DayInvestor Earnings Call - Vinanet
Lantheus Wins FDA Approval for Alzheimer's Tau PET Imaging Agent - finance.biggo.com
B.Riley downgrades Lantheus stock rating on Curium acquisition By Investing.com - Investing.com Australia
B.Riley downgrades Lantheus stock rating on Curium acquisition - Investing.com Nigeria
FDA approves Lantheus tau PET imaging agent for Alzheimer’s disease - DOTmed
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 6.21% Potential Upside - DirectorsTalk Interviews
Tauklarify PET approval for Lantheus in AD NFT pathology - pharmaphorum
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics - Sahm
What Does Lantheus Holdings (LNTH) FDA Approval Mean For Its Alzheimer’s Push? - webull.com
Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals - RTTNews
US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment - KWSN
LNTH Looks 10.1% Overvalued on GF Value™ - GuruFocus
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters
Lantheus Wins FDA Approval for Alzheimer's Tau Imaging Agent Tauklarify - marketscreener.com
Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s - Seeking Alpha
FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease - Investing.com
FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease By Investing.com - Investing.com Nigeria
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease - The Manila Times
FDA approves Lantheus brain scan to identify tau in Alzheimer’s - Stock Titan
Farallon group (LNTH) discloses 5.58M-share, 8.6% position in Lantheus - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
(LNTH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowman Consulting Group Ltd. (Nasdaq – BWMN), Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insuran - WBOC TV
Pacer Advisors Inc. Reduces Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - globenewswire.com
Lantheus Holdings: Why I Am Exiting Before The Merger Closes (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio - DirectorsTalk Interviews
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lantheus Holdings Inc Stock (LNTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings, Inc. | 10% Owner |
Sep 01 '26 |
Sale |
3.12 |
35,769 |
111,574 |
11,563,425 |
| Lantheus Holdings, Inc. | 10% Owner |
Aug 31 '26 |
Sale |
3.14 |
78,145 |
245,610 |
11,599,194 |
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):